Legal Charge Slashes GlaxoSmithKline Quarterly Profit, Glaxo Said to Have Paid $1 Billion Over Paxil Suits

Reuters -- GlaxoSmithKline (GSK.L) earnings slumped 92 percent in the second quarter, hit by a big charge to settle litigation over diabetes pill Avandia, antidepressant Paxil and a former factory in Puerto Rico.